Clinical trial

Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL)…

NCT00405652 · Novartis Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00405652
Title Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients
Official title Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients (MyLiver)
Lead sponsor Novartis Pharmaceuticals, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Liver Transplantation
Intervention type Drug
Interventions Enteric-coated Mycophenolate sodium (EC-MPS)
Enrollment 34
Start date Jan 1, 2007
Primary completion Sep 1, 2008
Completion Sep 1, 2008
First posted Nov 30, 2006
Last update posted Mar 3, 2011
Countries Germany

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies